PAXX binding to the NHEJ machinery explains functional redundancy with XLF.


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
02 06 2023
Historique:
medline: 2 6 2023
pubmed: 31 5 2023
entrez: 31 5 2023
Statut: ppublish

Résumé

Nonhomologous end joining is a critical mechanism that repairs DNA double-strand breaks in human cells. In this work, we address the structural and functional role of the accessory protein PAXX [paralog of x-ray repair cross-complementing protein 4 (XRCC4) and XRCC4-like factor (XLF)] in this mechanism. Here, we report high-resolution cryo-electron microscopy (cryo-EM) and x-ray crystallography structures of the PAXX C-terminal Ku-binding motif bound to Ku70/80 and cryo-EM structures of PAXX bound to two alternate DNA-dependent protein kinase (DNA-PK) end-bridging dimers, mediated by either Ku80 or XLF. We identify residues critical for the Ku70/PAXX interaction in vitro and in cells. We demonstrate that PAXX and XLF can bind simultaneously to the Ku heterodimer and act as structural bridges in alternate forms of DNA-PK dimers. Last, we show that engagement of both proteins provides a complementary advantage for DNA end synapsis and end joining in cells.

Identifiants

pubmed: 37256950
doi: 10.1126/sciadv.adg2834
pmc: PMC10413649
doi:

Substances chimiques

DNA 9007-49-2
DNA Repair Enzymes EC 6.5.1.-
O-(5-O-(4-coumaroyl)-alpha-arabinofuranosyl)-(1-3)-O-beta-xylopyranosyl-(1-4)-xylopyranose 102254-69-3
NHEJ1 protein, human 0
PAXX protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadg2834

Subventions

Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/X00029X/1
Pays : United Kingdom

Commentaires et corrections

Type : ErratumIn

Références

Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42
pubmed: 21460441
Cell Cycle. 2017 Feb;16(3):286-295
pubmed: 27830975
Cell Rep. 2016 Sep 13;16(11):2967-2979
pubmed: 27601299
Prog Biophys Mol Biol. 2015 Mar;117(2-3):194-205
pubmed: 25550082
FEBS Open Bio. 2018 Feb 04;8(3):426-434
pubmed: 29511619
DNA Repair (Amst). 2017 Oct;58:29-37
pubmed: 28846869
Protein Sci. 2021 Jan;30(1):70-82
pubmed: 32881101
Cell Rep. 2016 Oct 4;17(2):541-555
pubmed: 27705800
Genome Res. 2004 Jun;14(6):1188-90
pubmed: 15173120
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):293-302
pubmed: 21460447
FEBS Open Bio. 2018 Feb 07;8(3):442-448
pubmed: 29511621
J Cell Biol. 2013 Jan 21;200(2):173-86
pubmed: 23337116
Cell Death Differ. 2018 Feb;25(2):444-452
pubmed: 29077092
Proc Natl Acad Sci U S A. 2017 Jul 11;114(28):7367-7372
pubmed: 28652322
Annu Rev Biochem. 2021 Jun 20;90:137-164
pubmed: 33556282
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Genes Dev. 2016 Oct 1;30(19):2152-2157
pubmed: 27798842
Nat Rev Mol Cell Biol. 2020 Dec;21(12):765-781
pubmed: 33077885
Mol Cell Biol. 2007 May;27(10):3881-90
pubmed: 17353268
Front Immunol. 2022 Mar 02;13:852453
pubmed: 35309348
Proc Natl Acad Sci U S A. 2016 Sep 20;113(38):10619-24
pubmed: 27601633
Front Mol Biosci. 2020 Oct 23;7:584053
pubmed: 33195430
PLoS One. 2014 Dec 31;9(12):e115318
pubmed: 25551825
Nucleic Acids Res. 2003 Dec 15;31(24):7238-46
pubmed: 14654699
Nat Commun. 2018 Sep 24;9(1):3877
pubmed: 30250067
Science. 2015 Jan 9;347(6218):185-188
pubmed: 25574025
Nature. 2001 Aug 9;412(6847):607-14
pubmed: 11493912
Adv Immunol. 2008;99:33-58
pubmed: 19117531
J Biol Chem. 2005 Feb 25;280(8):7060-9
pubmed: 15520013
Bioinformatics. 2007 Feb 15;23(4):427-33
pubmed: 17150992
Prog Biophys Mol Biol. 2019 Oct;147:62-76
pubmed: 30851288
Nat Struct Mol Biol. 2018 Jun;25(6):482-487
pubmed: 29786079
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nat Struct Mol Biol. 2021 Jan;28(1):13-19
pubmed: 33077952
Nat Struct Mol Biol. 2018 Oct;25(10):971-980
pubmed: 30291363
Trends Genet. 2021 Jun;37(6):582-599
pubmed: 33785198
Nucleic Acids Res. 2007;35(11):3535-50
pubmed: 17483520
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Mol Cell. 2021 Aug 19;81(16):3400-3409.e3
pubmed: 34352203
Cell Rep. 2016 Apr 5;15(1):210-218
pubmed: 27052166
Nat Commun. 2015 Feb 11;6:6233
pubmed: 25670504
Mol Cell. 2016 Mar 17;61(6):850-8
pubmed: 26990988
Nature. 2021 May;593(7858):294-298
pubmed: 33854234
Nat Commun. 2017 Jan 04;8:13816
pubmed: 28051062
Nucleic Acids Res. 2011 Dec;39(22):9605-19
pubmed: 21880593
Mol Cell Biol. 2015 Sep 1;35(17):3017-28
pubmed: 26100018

Auteurs

Murielle Seif-El-Dahan (M)

Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, CEA, CNRS, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France.

Antonia Kefala-Stavridi (A)

Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge CB2 1GA, UK.

Philippe Frit (P)

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Steven W Hardwick (SW)

Cryo-EM Facility, Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge CB2 1GA, UK.

Dima Y Chirgadze (DY)

Cryo-EM Facility, Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge CB2 1GA, UK.

Taiana Maia De Oliviera (T)

AstraZeneca R&D, Discovery Sciences, Mechanistic and Structural Biology, Cambridge, UK.

Jessica Andreani (J)

Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, CEA, CNRS, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France.

Sébastien Britton (S)

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Nadia Barboule (N)

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Madeleine Bossaert (M)

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Arun Prasad Pandurangan (AP)

Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge CB2 1GA, UK.

Katheryn Meek (K)

College of Veterinary Medicine, Department of Microbiology & Molecular Genetics, Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA.

Tom L Blundell (TL)

Department of Biochemistry, University of Cambridge, Sanger Building, Tennis Court Road, Cambridge CB2 1GA, UK.

Virginie Ropars (V)

Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, CEA, CNRS, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France.

Patrick Calsou (P)

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

Jean-Baptiste Charbonnier (JB)

Institute for Integrative Biology of the Cell (I2BC), Institute Joliot, CEA, CNRS, Université Paris-Saclay, 91198 Gif-sur-Yvette cedex, France.

Amanda K Chaplin (AK)

Leicester Institute for Structural and Chemical Biology, Department of Molecular and Cell Biology, University of Leicester, Leicester, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH